MilliporeSigma

HMDB: a knowledgebase for the human metabolome.

Nucleic acids research (2008-10-28)
David S Wishart, Craig Knox, An Chi Guo, Roman Eisner, Nelson Young, Bijaya Gautam, David D Hau, Nick Psychogios, Edison Dong, Souhaila Bouatra, Rupasri Mandal, Igor Sinelnikov, Jianguo Xia, Leslie Jia, Joseph A Cruz, Emilia Lim, Constance A Sobsey, Savita Shrivastava, Paul Huang, Philip Liu, Lydia Fang, Jun Peng, Ryan Fradette, Dean Cheng, Dan Tzur, Melisa Clements, Avalyn Lewis, Andrea De Souza, Azaret Zuniga, Margot Dawe, Yeping Xiong, Derrick Clive, Russ Greiner, Alsu Nazyrova, Rustem Shaykhutdinov, Liang Li, Hans J Vogel, Ian Forsythe
ABSTRACT

The Human Metabolome Database (HMDB, http://www.hmdb.ca) is a richly annotated resource that is designed to address the broad needs of biochemists, clinical chemists, physicians, medical geneticists, nutritionists and members of the metabolomics community. Since its first release in 2007, the HMDB has been used to facilitate the research for nearly 100 published studies in metabolomics, clinical biochemistry and systems biology. The most recent release of HMDB (version 2.0) has been significantly expanded and enhanced over the previous release (version 1.0). In particular, the number of fully annotated metabolite entries has grown from 2180 to more than 6800 (a 300% increase), while the number of metabolites with biofluid or tissue concentration data has grown by a factor of five (from 883 to 4413). Similarly, the number of purified compounds with reference to NMR, LC-MS and GC-MS spectra has more than doubled (from 380 to more than 790 compounds). In addition to this significant expansion in database size, many new database searching tools and new data content has been added or enhanced. These include better algorithms for spectral searching and matching, more powerful chemical substructure searches, faster text searching software, as well as dedicated pathway searching tools and customized, clickable metabolic maps. Changes to the user-interface have also been implemented to accommodate future expansion and to make database navigation much easier. These improvements should make the HMDB much more useful to a much wider community of users.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
20-Hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoic acid, ~100 μg/mL in ethanol, ≥90% (HPLC)
Sigma-Aldrich
Reagent Alcohol, anhydrous, ≤0.005% water
Sigma-Aldrich
Betaine solution, 5 M, PCR Reagent
Supelco
Sucrose, analytical standard, for enzymatic assay kit SCA20
Sigma-Aldrich
Lipoxin A4, ethanol solution
Sigma-Aldrich
myo-Inositol, ≥99%
Sigma-Aldrich
Prostaglandin E2, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
cis-Aconitic acid, ≥98%
Millipore
myo-Inositol, suitable for microbiology, ≥99.0%
Sigma-Aldrich
L-Tyrosine, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
L-Valine, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
γ-Linolenic acid, ≥99%, liquid
Sigma-Aldrich
Glycolic acid, BioXtra, ≥98.0% (titration)
Sigma-Aldrich
L-Alanine, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Hippuric acid, 98%
Sigma-Aldrich
Formic acid, ≥95%, FCC, FG
Sigma-Aldrich
α-Hydroxyisobutyric acid, 98%
Sigma-Aldrich
D-Mannitol, tested according to Ph. Eur.
Sigma-Aldrich
Trimethylamine solution, 25 wt. % in propylene glycol
Sigma-Aldrich
Glycolic acid solution, technical grade, 70 wt. % in H2O
Sigma-Aldrich
Palmitic acid, ≥98%, FCC, FG
Sigma-Aldrich
Trimethylamine solution, 43.0-49.0% in H2O (T)
Supelco
D-Mannitol, ≥99.9999% (metals basis), for boron determination
Millipore
D-Mannitol, ACS reagent, suitable for microbiology, ≥99.0%
Mannitol, European Pharmacopoeia (EP) Reference Standard
Palmitic acid, European Pharmacopoeia (EP) Reference Standard
Sucrose, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Palmitic acid, natural, 98%, FG
Supelco
Myristic acid, Pharmaceutical Secondary Standard; Certified Reference Material